Loading…
CIK 0001776382 • 6 13F filings • May 15, 2025 – Aug 14, 2026
Import this data to Google Sheets with:
=jivedata("venbio-partners-llc","13f")Uses this filer's slug. Install the Jive Data add-on first; the second argument is "13f".
Past 5 quarters
| % of Portfolio | |||||
|---|---|---|---|---|---|
| ACHIEVE LIFE SCIENCE INC | COM | $38.6M | 7.4% | 5,914,720 SH | New |
| ALUMIS INC | COM | $127.4M | 24.5%Prev: 12.1% | 4,528,408 SH | Increased-91,395 SH |
| ALX ONCOLOGY HLDGS INC | COM | $26.7M | 5.1%Prev: 3.5% | 12,884,638 SH | Increased+3,184,713 SH |
| HARMONY BIOSCIENCES HLDGS IN | COM | $17.2M | 3.3%Prev: 13.5% | 472,194 SH | Increased-17,000 SH |
| LYELL IMMUNOPHARMA INC | COM NEW | $4.7M | 0.9%Prev: 3.6% | 337,697 SH | Increased-135,782 SH |
| PARABILIS MEDICINES INC | COM | $144.1M | 27.8% | 5,266,697 SH | New |
| PHARVARIS N V | COM | $160.6M | 30.9%Prev: 65.8% | 4,643,430 SH | Increased+354,126 SH |
| 13F-HR |
| 0000905148-26-003741 |
| $519.4M |
| View |
| Aug 14, 2025 | Q2 2025 | 13F-HR | 0000905148-25-002929 | $114.8M | View |
| May 15, 2026 | Q1 2026 | 13F-HR | 0000905148-26-002409 | $280.6M | View |
| May 15, 2025 | Q1 2025 | 13F-HR | 0000905148-25-001748 | $123.6M | View |